A detailed history of Israel Englander (Millennium Management LLC) transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 10,000 shares of KROS stock, worth $664,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 337,663 97.04%
Holding current value
$664,500
Previous $22.4 Million 97.96%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$44.58 - $66.89 $2.46 Million - $3.7 Million
55,293 Added 16.38%
392,956 $18 Million
Q1 2024

May 15, 2024

SELL
$41.26 - $70.48 $7.61 Million - $13 Million
-184,465 Reduced 35.33%
337,663 $22.4 Million
Q4 2023

Feb 14, 2024

BUY
$27.12 - $41.05 $13.1 Million - $19.8 Million
482,232 Added 1208.72%
522,128 $20.8 Million
Q2 2023

Aug 14, 2023

BUY
$37.26 - $51.01 $578,386 - $791,828
15,523 Added 63.69%
39,896 $1.6 Million
Q1 2023

May 15, 2023

SELL
$41.44 - $59.32 $6.5 Million - $9.31 Million
-156,904 Reduced 86.55%
24,373 $1.04 Million
Q4 2022

Feb 14, 2023

BUY
$39.45 - $51.77 $7.15 Million - $9.38 Million
181,277 New
181,277 $8.71 Million
Q2 2022

Aug 15, 2022

SELL
$26.03 - $67.04 $1.71 Million - $4.4 Million
-65,688 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$42.12 - $59.36 $545,201 - $768,355
12,944 Added 24.54%
65,688 $3.57 Million
Q4 2021

Feb 14, 2022

SELL
$36.95 - $62.89 $4.77 Million - $8.12 Million
-129,132 Reduced 71.0%
52,744 $3.09 Million
Q3 2021

Nov 15, 2021

BUY
$29.27 - $43.71 $1.9 Million - $2.84 Million
64,961 Added 55.56%
181,876 $7.2 Million
Q2 2021

Aug 16, 2021

SELL
$42.4 - $70.11 $566,040 - $935,968
-13,350 Reduced 10.25%
116,915 $4.97 Million
Q1 2021

May 17, 2021

BUY
$54.0 - $75.28 $2.28 Million - $3.19 Million
42,309 Added 48.1%
130,265 $8.02 Million
Q4 2020

Feb 16, 2021

BUY
$36.0 - $82.74 $2.85 Million - $6.55 Million
79,217 Added 906.48%
87,956 $6.2 Million
Q3 2020

Nov 16, 2020

BUY
$27.04 - $62.21 $236,302 - $543,653
8,739 New
8,739 $337,000

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.71B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.